Advertisement
Screener

VERICEL CORPORATION (VCEL) Increase (Decrease) in Receivables

VERICEL CORPORATION Increase (Decrease) in Receivables

VERICEL CORPORATION (VCEL) reported Increase (Decrease) in Receivables of -$8.92 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInReceivables · last filed 2026-07-30

  • VERICEL CORPORATION increase (decrease) in receivables for the quarter ending 2026-06-30 was $3.33M, a 70.78% decline year-over-year.
  • VERICEL CORPORATION increase (decrease) in receivables for the quarter ending 2026-03-31 was -$12.25M.
  • VERICEL CORPORATION increase (decrease) in receivables for the quarter ending 2025-12-31 was $24.21M, a 87.72% increase year-over-year.
  • VERICEL CORPORATION increase (decrease) in receivables for the quarter ending 2025-09-30 was -$3.86M, a 900.00% decline year-over-year.
  • VERICEL CORPORATION increase (decrease) in receivables for fiscal 2025 was $23.26M, a 670.42% increase from fiscal 2024.
  • VERICEL CORPORATION increase (decrease) in receivables for fiscal 2024 was $3.02M, a 74.45% decline from fiscal 2023.
  • VERICEL CORPORATION increase (decrease) in receivables for fiscal 2023 was $11.82M, a 29.83% increase from fiscal 2022.
  • VERICEL CORPORATION increase (decrease) in receivables for fiscal 2022 was $9.10M, a 210.33% increase from fiscal 2021.
Period endIncrease (Decrease) in Receivables 3 monthIncrease (Decrease) in Receivables 6 monthIncrease (Decrease) in Receivables 9 monthIncrease (Decrease) in Receivables 12 monthIncrease (Decrease) in Receivables 267 monthIncrease (Decrease) in Receivables 270 monthIncrease (Decrease) in Receivables 273 monthIncrease (Decrease) in Receivables 276 monthIncrease (Decrease) in Receivables 279 monthIncrease (Decrease) in Receivables 282 monthIncrease (Decrease) in Receivables 285 month
2026-06-30$3.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
-$8.92M
10-Q · filed 2026-07-30
$15.29M
derived: sum of 3 quarters · filed 2026-07-30
$11.42M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31-$12.25M
10-Q · filed 2026-05-07
$11.96M
derived: sum of 2 quarters · filed 2026-05-07
$8.09M
derived: sum of 3 quarters · filed 2026-05-07
$19.48M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$24.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$20.34M
derived: sum of 2 quarters · filed 2026-02-26
$31.73M
derived: sum of 3 quarters · filed 2026-07-30
$23.26M
10-K · filed 2026-02-26
2025-09-30-$3.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$7.53M
derived: sum of 2 quarters · filed 2026-07-30
-$949.00K
10-Q · filed 2025-11-06
$11.95M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$11.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$2.92M
10-Q · filed 2026-07-30
$15.81M
derived: sum of 3 quarters · filed 2026-07-30
$16.29M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31-$8.48M
10-Q · filed 2026-05-07
$4.42M
derived: sum of 2 quarters · filed 2026-05-07
$4.90M
derived: sum of 3 quarters · filed 2026-05-07
$2.96M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$12.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$13.38M
derived: sum of 2 quarters · filed 2026-02-26
$11.44M
derived: sum of 3 quarters · filed 2026-02-26
$3.02M
10-K · filed 2026-02-26
2024-09-30$483.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$1.46M
derived: sum of 2 quarters · filed 2025-11-06
-$9.88M
10-Q · filed 2025-11-06
$8.75M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$1.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
-$10.36M
10-Q · filed 2025-07-31
$8.27M
derived: sum of 3 quarters · filed 2026-02-26
$9.68M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31-$8.42M
10-Q · filed 2025-05-08
$10.21M
derived: sum of 2 quarters · filed 2026-02-26
$11.62M
derived: sum of 3 quarters · filed 2026-02-26
$11.57M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$18.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$20.04M
derived: sum of 2 quarters · filed 2026-02-26
$20.00M
derived: sum of 3 quarters · filed 2026-02-26
$11.82M
10-K · filed 2026-02-26
2023-09-30$1.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$1.37M
derived: sum of 2 quarters · filed 2024-11-07
-$6.81M
10-Q · filed 2024-11-07
$5.43M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$40.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
-$8.22M
10-Q · filed 2024-08-01
$4.02M
derived: sum of 3 quarters · filed 2025-02-27
$4.66M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$8.18M
10-Q · filed 2024-05-08
$4.06M
derived: sum of 2 quarters · filed 2025-02-27
$4.70M
derived: sum of 3 quarters · filed 2025-02-27
$6.50M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$12.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$12.88M
derived: sum of 2 quarters · filed 2025-02-27
$14.68M
derived: sum of 3 quarters · filed 2025-02-27
$9.10M
10-K · filed 2025-02-27
2022-09-30$632.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$2.44M
derived: sum of 2 quarters · filed 2023-11-08
-$3.14M
10-Q · filed 2023-11-08
$5.39M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$1.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
-$3.77M
10-Q · filed 2023-08-02
$4.75M
derived: sum of 3 quarters · filed 2024-02-29
$1.93M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$5.58M
10-Q · filed 2023-05-10
$2.94M
derived: sum of 2 quarters · filed 2024-02-29
$123.00K
derived: sum of 3 quarters · filed 2024-02-29
$2.73M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$8.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$5.71M
derived: sum of 2 quarters · filed 2024-02-29
$8.31M
derived: sum of 3 quarters · filed 2024-02-29
$2.93M
10-K · filed 2024-02-29
2021-09-30-$2.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$212.00K
derived: sum of 2 quarters · filed 2022-11-09
-$5.59M
10-Q · filed 2022-11-09
$2.74M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$2.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
-$2.77M
10-Q · filed 2022-08-03
$5.56M
derived: sum of 3 quarters · filed 2023-02-23
$8.08M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31-$5.38M
10-Q · filed 2022-05-04
$2.95M
derived: sum of 2 quarters · filed 2023-02-23
$5.47M
derived: sum of 3 quarters · filed 2023-02-23
$4.95M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$8.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$10.85M
derived: sum of 2 quarters · filed 2023-02-23
$10.33M
derived: sum of 3 quarters · filed 2023-02-23
$2.34M
10-K · filed 2023-02-23
2020-09-30$2.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$2.00M
derived: sum of 2 quarters · filed 2021-11-09
-$5.99M
10-Q · filed 2021-11-09
$6.22M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30-$516.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
-$8.51M
10-Q · filed 2021-08-04
$3.70M
derived: sum of 3 quarters · filed 2022-02-24
$2.57M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$8.00M
10-Q · filed 2021-05-05
$4.21M
derived: sum of 2 quarters · filed 2022-02-24
$3.09M
derived: sum of 3 quarters · filed 2022-02-24
$5.40M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$12.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$11.08M
derived: sum of 2 quarters · filed 2022-02-24
$13.39M
derived: sum of 3 quarters · filed 2022-02-24
$8.71M
10-K · filed 2022-02-24
2019-09-30-$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$1.18M
derived: sum of 2 quarters · filed 2020-11-05
-$3.50M
10-Q · filed 2020-11-05
$4.43M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$2.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
-$2.37M
10-Q · filed 2020-08-05
$5.56M
derived: sum of 3 quarters · filed 2021-02-24
$3.58M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31-$4.68M
10-Q · filed 2020-05-11
$3.25M
derived: sum of 2 quarters · filed 2021-02-24
$1.27M
derived: sum of 3 quarters · filed 2021-02-24
$5.61M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$7.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$5.96M
derived: sum of 2 quarters · filed 2021-02-24
$10.29M
derived: sum of 3 quarters · filed 2021-02-24
$5.18M
10-K · filed 2021-02-24
2018-09-30-$1.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$2.37M
derived: sum of 2 quarters · filed 2019-11-05
-$2.74M
10-Q · filed 2019-11-05
$98.00K
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$4.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$771.00K
10-Q · filed 2019-08-06
$2.07M
derived: sum of 3 quarters · filed 2020-02-25
$2.77M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$5.11M
10-Q · filed 2019-05-07
-$2.27M
derived: sum of 2 quarters · filed 2020-02-25
-$1.57M
derived: sum of 3 quarters · filed 2020-02-25
$1.03M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$2.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$3.54M
derived: sum of 2 quarters · filed 2020-02-25
$6.14M
derived: sum of 3 quarters · filed 2020-02-25
$1.18M
10-K · filed 2020-02-25
2017-09-30$701.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$3.30M
derived: sum of 2 quarters · filed 2018-11-06
-$1.66M
10-Q · filed 2018-11-06
$7.56M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$2.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
-$2.36M
10-Q · filed 2018-08-06
$6.86M
derived: sum of 3 quarters · filed 2019-02-26
$5.70M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31-$4.97M
10-Q · filed 2018-05-08
$4.26M
derived: sum of 2 quarters · filed 2019-02-26
$3.10M
derived: sum of 3 quarters · filed 2019-02-26
$2.46M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$9.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$8.06M
derived: sum of 2 quarters · filed 2019-02-26
$7.42M
derived: sum of 3 quarters · filed 2019-02-26
$6.17M
10-K · filed 2019-02-26
2016-09-30-$1.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
-$1.80M
derived: sum of 2 quarters · filed 2017-11-07
-$3.05M
10-Q · filed 2017-11-07
$232.00K
derived: sum of 4 quarters · filed 2018-03-05
2016-06-30-$638.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$1.89M
10-Q · filed 2017-08-09
$1.39M
derived: sum of 3 quarters · filed 2018-03-05
$51.00K
derived: sum of 4 quarters · filed 2018-03-05
2016-03-31-$1.25M
10-Q · filed 2017-05-10
$2.03M
derived: sum of 2 quarters · filed 2018-03-05
$689.00K
derived: sum of 3 quarters · filed 2018-03-05
$503.00K
derived: sum of 4 quarters · filed 2018-03-05
2015-12-31$3.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$1.94M
derived: sum of 2 quarters · filed 2018-03-05
$1.75M
derived: sum of 3 quarters · filed 2018-03-05
$2.73M
10-K · filed 2018-03-05
2015-09-30-$1.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
-$1.53M
derived: sum of 2 quarters · filed 2016-11-07
-$552.00K
10-Q · filed 2016-11-07
$3.66M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30-$186.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$789.00K
10-Q · filed 2016-08-08
$5.00M
derived: sum of 3 quarters · filed 2017-03-13
$4.67M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$975.00K
10-Q · filed 2016-05-10
$5.18M
derived: sum of 2 quarters · filed 2017-03-13
$4.86M
derived: sum of 3 quarters · filed 2017-03-13
$9.11M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$4.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$3.88M
derived: sum of 2 quarters · filed 2017-03-13
$8.14M
derived: sum of 3 quarters · filed 2017-03-13
$8.14M
10-K · filed 2017-03-13
2014-09-30-$326.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
$3.93M
derived: sum of 2 quarters · filed 2015-11-13
$3.93M
10-Q · filed 2015-11-13
2014-06-30$4.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
$4.26M
10-Q · filed 2015-08-12
2014-03-31$0.00
10-Q · filed 2015-05-14
2013-12-31$0.00
10-K · filed 2016-03-14
2013-06-30-$24.00K
10-Q · filed 2014-08-14
2012-12-31$19.00K
derived: 10-K 285 month − 10-Q 282 month · filed 2013-03-18
$19.00K
derived: sum of 2 quarters · filed 2013-03-18
$17.00K
derived: sum of 3 quarters · filed 2013-03-18
$19.00K
10-K · filed 2013-03-18
$277.00K
10-K · filed 2013-03-18
2012-09-30$0.00
derived: 10-Q 282 month − 10-Q 279 month · filed 2012-11-08
-$2.00K
derived: sum of 2 quarters · filed 2012-11-08
$0.00
derived: sum of 3 quarters · filed 2012-11-08
$0.00
derived: sum of 4 quarters · filed 2013-03-18
$258.00K
10-Q · filed 2012-11-08
2012-06-30-$2.00K
derived: 10-Q 279 month − 10-Q 276 month · filed 2012-08-07
$0.00
derived: sum of 2 quarters · filed 2012-08-07
$0.00
derived: sum of 3 quarters · filed 2013-03-18
$9.00K
derived: sum of 4 quarters · filed 2013-03-18
$258.00K
10-Q · filed 2012-08-07
2012-03-31$2.00K
10-Q · filed 2012-05-10
$2.00K
derived: sum of 2 quarters · filed 2013-03-18
$11.00K
derived: sum of 3 quarters · filed 2013-03-18
-$7.00K
derived: sum of 4 quarters · filed 2013-03-18
$260.00K
10-Q · filed 2012-05-10
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$9.00K
derived: sum of 2 quarters · filed 2013-03-18
-$9.00K
derived: sum of 3 quarters · filed 2013-03-18
-$16.00K
10-K · filed 2013-03-18
$258.00K
10-K · filed 2012-03-15
2011-09-30$9.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
-$9.00K
derived: sum of 2 quarters · filed 2012-11-08
-$16.00K
10-Q · filed 2012-11-08
$258.00K
10-Q · filed 2011-11-08
2011-06-30-$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
-$25.00K
10-Q · filed 2012-08-07
$249.00K
10-Q · filed 2011-08-15
2011-03-31-$7.00K
10-Q · filed 2012-05-10
2010-12-31$9.00K
10-K · filed 2013-03-18
2010-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
-$6.00K
10-Q · filed 2011-11-08
2010-06-30-$7.00K
10-Q · filed 2011-08-15
-$42.00K
10-K · filed 2013-03-18
2009-06-30$40.00K
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Greenland Mines Ltd (GRML)United States$2.362B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80